Reduced peak inspiratory effort through the Diskus® and the Turbuhaler® due to mishandling is common in clinical practice

Clinical Drug Investigation

Volumn 25, Issue 8, 2005, Pages 543-549

  Melani, Andrea S ^a   Bracci, Letizia S ^a   Rossi, Marcello ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; COUNSELING; DEVICE; DRUG DELIVERY SYSTEM; FEEDBACK SYSTEM; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION; LABORATORY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PREDICTION; PRIORITY JOURNAL;

EID: 23044465131     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200525080-00007     Document Type: Article

References (28)

1. Crompton GK. Problems patients have using pressurised aerosol inhalers. Eur J Respir Dis 1982; 63 Suppl. 119: 101-4
2. Melani AS, Zanchetta D, Barbato N, et al. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol 2004; 93: 439-46
3. Clarke AR, Hollingworth AM. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers: implications for in vitro testing. J Aerosol Med 1993; 6: 99-110
4. Bisgaard H, Klug B, Sumby BS, et al. Fine particle mass from the Diskus inhaler and Turbuhaler inhaler in children with asthma. Eur Respir J 1998; 11: 1111-5
5. Engel T, Heinig JH, Madsen F, et al. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler). Eur Respir J 1990; 3: 1037-41
6. Newman SP, Morén F, Trofast E, et al. Terbutaline sulphate Turbuhaler: effect of inhaled flow rate and drug deposition and efficacy. Int J Pharm 1991; 74: 209-13
7. Nielsen KG, Auk IL, Bojsen K, et al. Clinical effect of Diskus™ dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children. Eur Respir J 1998; 11: 350-4
8. Brindley A, Sumby BS, Smith IJ, et al. Design, manufacture and dose consistency of the Serevent Diskus inhaler. Pharm Technol Eur 1995; 7: 14-22
9. Fuller R. The Diskus: a new multi-dose powder device: efficacy and comparison with Turbuhaler. J Aerosol Med 1995; 8: S11-7
10. Brown PH, Ning ACWS, Greening AP, et al. Peak inspiratory flow through Turbuhaler® in acute asthma. Eur Respir J 1995; 8: 19401-1941
11. Nsour WM, Alldred A, Corrado OJ, et al. Measurement of peak inhalation rates with an In-Check Meter® to identify an elderly patient's ability to use a Turbuhaler®. Respir Med 2001; 95: 965-8
12. Dewar MH, Jamieson A, McLean A, et al. Peak inspiratory flow through Turbuhaler® in chronic obstructive airways disease. Respir Med 1999; 93: 342-4
13. Bisgaard H, Pedersen S, Nikander K. Use of budesonide Turbuhaler® in young children suspected of asthma. Eur Respir J 1994; 7: 740-2
14. Van Beeredonk I, Mesters I, Mudde AN, et al. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J Asthma 1998; 35: 273-9
15. Melani AS, Franchi C, Pirrelli M. An evaluation of the inhalation technique in 103 adult users of both Turbohaler® dry powder inhaler and conventional pressurised metered dose inhalers. Rassegna di Patologia dell'Apparato Respiratorio 1999; 14: 186-92
16. van der Palen J, Klein JJ, van Herwaarden CLA, et al. Multiple inhalers confuse asthma patients. Eur Respir J 1999; 14: 1034-7
17. Branco Ferreira M, Santos A, Clode MH, et al. Turbotest™ in the training of asthmatic Turbuhaler™ users. Allergy 1999; 54: 375-9
18. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir Med 2000; 94: 496-500
19. Epstein S, Maidenberg A, Hallett D, et al. Patient handling of a dry-powder inhaler in clinical practice. Chest 2001; 120: 1480-4
20. Hawksworth GM, James L, Chrystyn H. Characterization of the inspiratory manoeuvre when asthmatics inhale through a Turbohaler pre- and post-counselling in a community pharmacy. Respir Med 2000; 94: 501-4
21. Broeders MEAC, Molema J, Hop WJC, et al. Inhalation profiles in asthma and COPD patients: reproducibility and effect of instruction. J Aerosol Med 2003; 16: 131-4
22. Kamin WE, Genz T, Roeder S, et al. The inhalation manager: a new computer-based device to assess inhalation technique and drug delivery to the patient. J Aerosol Med 2003; 16: 21-9
23. Steier J, Trammer T, Cloes RM, et al. Optical feedback training of inhalation with Autohaler and Turbuhaler in COPD patients. Lung 2003; 181: 183-92
24. Van der Palen J. Peak inspiratory flow through Diskus and Turbuhaler, measured by means of a peak inspiratory flow meter (In-Check Dial®). Respir Med 2003; 97: 285-9
25. Chrystyn H. Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates. Respir Med 2003; 97: 181-7
26. Broeders MEAC, Molema J, Vermue NA, et al. In Check Dial: accuracy for Diskus and Turbuhaler. Int J Pharm 2003; 252: 275-80
27. Bentur L, Mansour Y, Hamzani Y, et al. Measurement of inspiratory flow in children with acute asthma. Pediatr Pulmonol 2004; 38: 304-7
28. Amirav I, Newhouse MT, Mansour Y. Measurement of peak inspiratory flow with In-Check Dial device to simulate lowresistance (Diskus) and high-resistance (Turbuhaler) dry powder inhalers in children with asthma. Pediatr Pulmonol 2005; 39: 447-51